FELÇLİLERE ÇARE: SİBERNETİK TIP MÜHENDİSLİĞİ/CYBERNETIC MEDICAL ENGINEERING FOR PARALYSIS

Sibernetik Tıp Mühendisliği, tetrapelji (traplagia) , omurilik hasarları (spinal cord injuries), sinir harabiyeti olmaksızın kasların gücünü kaybetmesi (mascular distrophy), ALS (amyotrophic lateral sclerosis (ALS)) veya diğer motor sinir (nöron) hastalıkları (motor neuron diseases)’na çare olmaya devam ediyor.

fesjournal-1_custom-9bfa4577032acb8697c16d2a6c06fea954bede8f-s600-c85

Benim de çalışma alanım içinde bulunan Sibernetik Tıp  uygulamaları ile, Massachusetts General Hastanesi (MGH), Case Western Reserve Üniversitesi ve ve Stanford Universitesi Tıp Merkezinde yapılan tedavilerle,  felçli hastalar rehabilite edilebilmektedir. Bu tedavi,  MasachuteBeyinGate 2 Sinir Arayüz Sistem çalışması (BrainGate 2 Neuron İnterface System)  (BrainGate2 Neural Interface System) isimli portokolle yapılmıştır.

Bu tedavi sonucu belli organlarını geçirilen bir sinirsel tahribat (felç durumu) sonucu kullanamayan kişilerin, bu organları ile beyni arasında bozulan sinirsel iletişimi, beyine yerleştirilen çipler ve bir dizi operasyon sonucu tekrar düzeltilmiştir. Bu tedavi sonucu, kişinin kolunu oynattığını düşünmesi ile birlikte, kolunu veya elini  oynatması sağlanmıştır.

Kaynak ve geniş bilgi: http://www.npr.org/sections/health-shots/2017/03/28/521665654/paralyzed-man-uses-thoughts-to-control-his-own-arm-and-hand

CLINICAL TRIALS FOR PARALYSIS

The purpose of the first phase of the pilot clinical study of the BrainGate2 Neural Interface System is to obtain preliminary device safety information and to demonstrate the feasibility of people with tetraplegia using the System to control a computer cursor and other assistive devices with their thoughts.

Another goal of the study is to determine the participants’ ability to operate communication software, such as e-mail, simply by imagining the movement of their own hand. The study is invasive and requires surgery.

Individuals with limited or no ability to use both hands due to cervical spinal cord injury, brainstem stroke, muscular dystrophy, or amyotrophic lateral sclerosis (ALS) or other motor neuron diseases are being recruited into a clinical study at Massachusetts General Hospital (MGH) Case Western Reserve University, Providence VA Medical Center, and Stanford University Medical Center. Clinical trial participants must live within a three-hour drive of Boston, MA, Cleveland, OH, Palo Alto, CA or Providence, RI. Clinical trial sites at other locations may be opened in the future. The study requires a commitment of 13 months.

Source: https://www.braingate.org/clinical-trials/

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.